螞蟻集團(688688.SH):H股發行價80港元 預計11月5日上市交易
格隆匯10月26日丨螞蟻集團(688688.SH)發佈H股全球發售的公告,本次H股發行價格為80.00港元。香港公開發售時間為2020年10月27日至2020年10月30日。本次發行的H股預計於2020年11月5日開始上市交易。
公司本次全球發售的H股股數為16.71億股,其中初步安排香港公開發售4176.8萬股,約佔全球發售H股總數的2.5%,國際發售16.29億股,約佔全球發售H股總數的97.5%。自2020年10月30日(即遞交香港公開發售申請最後期限之日)起30日內,聯席代表可代表國際承銷商通過行使超額配售選擇權,要求公司額外發售不超過2.51億股H股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.